✦ LIBER ✦

Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients

✍ Scribed by Kathryn A. Phillips; Deborah A. Marshall; Jennifer S. Haas; Elena B. Elkin; Su-Ying Liang; Michael J. Hassett; Ilia Ferrusi; Jane E. Brock; Stephanie L. Van Bebber

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 161 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24574

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical practice patterns and cost-effe

Clinical practice patterns and cost-effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients

✍ Patrick Fitzgibbons; Mary Kay Washington; Douglas Murphy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

Reply to Clinical practice patterns and

Reply to Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients

✍ Kathryn A. Phillips; Elena B. Elkin; Jennifer S. Haas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

The role of human epidermal growth facto

The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004

✍ Monica Brown; Alex Tsodikov; Katrina R. Bauer; Carol A. Parise; Vincent Caggiano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

## Abstract ## BACKGROUND Breast cancers that are negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (triple negative [TN]) have been associated with high‐grade histology, aggressive clinical behavior, and poor survival. It has been

Therapeutic effect of recombinant human

Therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer : A double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial

✍ Hong Gyun Wu; Si Yeol Song; Yeon Sil Kim; Young Taek Oh; Chang Geol Lee; Ki Chan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 1 views